Sanofi to Stop Late-Stage Study of Immune-Disorder DrugBy pgnnivash34@gmail.com / June 10, 2026 The termination is an early setback to new chief executive Belen Garijo, who took the helm last month. Source link About The Author pgnnivash34@gmail.com See author's posts